{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:28:52Z","timestamp":1774978132657,"version":"3.50.1"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2016CFB673"],"award-info":[{"award-number":["2016CFB673"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10741-019-09809-x","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T07:02:39Z","timestamp":1559890959000},"page":"1005-1017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["A review of fibroblast growth factor 21 in diabetic cardiomyopathy"],"prefix":"10.1007","volume":"24","author":[{"given":"Xiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yarong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"issue":"5","key":"9809_CR1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1210\/er.2017-00016","volume":"38","author":"H Staiger","year":"2017","unstructured":"Staiger H, Keuper M, Berti L, Hrabe DAM, Haring HU (2017 2017-10-01) Fibroblast growth factor 21-metabolic role in mice and men. Endocr Rev 38(5):468\u2013488","journal-title":"Endocr Rev"},{"issue":"3","key":"9809_CR2","first-page":"603","volume":"31","author":"L Recinella","year":"2017","unstructured":"Recinella L, Leone S, Ferrante C et al (2017 2017-07-01) Effects of central fibroblast growth factor 21 (FGF21) in energy balance. J Biol Regul Homeost Agents 31(3):603\u2013613","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"9809_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1","volume":"181","author":"SM Sheehan","year":"1999","unstructured":"Sheehan SM, Allen RE (1999 1999-12-01) Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J Cell Physiol 181(3):499\u2013506","journal-title":"J Cell Physiol"},{"issue":"9","key":"9809_CR4","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/humu.21067","volume":"30","author":"P Krejci","year":"2009","unstructured":"Krejci P, Prochazkova J, Bryja V, Kozubik A, Wilcox WR (2009 2009-09-01) Molecular pathology of the fibroblast growth factor family. Hum Mutat 30(9):1245\u20131255","journal-title":"Hum Mutat"},{"issue":"1","key":"9809_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/dvdy.21388","volume":"237","author":"N Itoh","year":"2008","unstructured":"Itoh N, Ornitz DM (2008 2008-01-01) Functional evolutionary history of the mouse Fgf gene family. Dev Dyn 237(1):18","journal-title":"Dev Dyn"},{"issue":"1","key":"9809_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","volume":"1492","author":"T Nishimura","year":"2000","unstructured":"Nishimura T, Nakatake Y, Konishi M, Itoh N (2000 2000-06-21) Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492(1):203\u2013206","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"9809_CR7","doi-asserted-by":"publisher","first-page":"12983","DOI":"10.1074\/jbc.M110.215889","volume":"286","author":"E Hondares","year":"2011","unstructured":"Hondares E, Iglesias R, Giralt A et al (2011 2011-04-15) Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J Biol Chem 286(15):12983\u201312990","journal-title":"J Biol Chem"},{"issue":"1","key":"9809_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41598-017-00349-8","volume":"7","author":"Y Nakayama","year":"2017","unstructured":"Nakayama Y, Masuda Y, Ohta H et al (2017 2017-03-23) Fgf21 regulates T-cell development in the neonatal and juvenile thymus. Sci Rep 7(1):330","journal-title":"Sci Rep"},{"issue":"9","key":"9809_CR9","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.2337\/db05-1435","volume":"55","author":"W Wente","year":"2006","unstructured":"Wente W, Efanov AM, Brenner M et al (2006 2006-09-01) Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1\/2 and Akt signaling pathways. Diabetes 55(9):2470\u20132478","journal-title":"Diabetes"},{"issue":"2","key":"9809_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jbior.2012.03.001","volume":"52","author":"JH Yoon","year":"2012","unstructured":"Yoon JH, Kim J, Song P, Lee TG, Suh PG, Ryu SH (2012 2012-05-01) Secretomics for skeletal muscle cells: a discovery of novel regulators? Adv Biol Regul 52(2):340\u2013350","journal-title":"Adv Biol Regul"},{"issue":"8","key":"9809_CR11","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00125-015-3630-8","volume":"58","author":"C Zhang","year":"2015","unstructured":"Zhang C, Huang Z, Gu J et al (2015 2015-08-01) Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1\/2-dependent signalling pathway. Diabetologia 58(8):1937\u20131948","journal-title":"Diabetologia"},{"issue":"9","key":"9809_CR12","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3249","volume":"19","author":"AL Bookout","year":"2013","unstructured":"Bookout AL, de Groot MH, Owen BM et al (2013 2013-09-01) FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat Med 19(9):1147\u20131152","journal-title":"Nat Med"},{"issue":"4","key":"9809_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0959-437X(95)90053-J","volume":"5","author":"TP Yamaguchi","year":"1995","unstructured":"Yamaguchi TP, Rossant J (1995 1995-08-01) Fibroblast growth factors in mammalian development. Curr Opin Genet Dev 5(4):485\u2013491","journal-title":"Curr Opin Genet Dev"},{"issue":"2","key":"9809_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar VP, Lax I, Schlessinger J (2005 2005-04-01) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16(2):139\u2013149","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"9809_CR15","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1128\/MCB.02249-06","volume":"27","author":"R Goetz","year":"2007","unstructured":"Goetz R, Beenken A, Ibrahimi OA et al (2007 2007-05-01) Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol 27(9):3417\u20133428","journal-title":"Mol Cell Biol"},{"issue":"7120","key":"9809_CR16","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T et al (2006 2006-12-07) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444(7120):770\u2013774","journal-title":"Nature"},{"key":"9809_CR17","unstructured":"Ogawa Y, Kurosu H, Yamamoto M, Nandi A, Rosenblatt KP. \u03b2 Klotho is required for metabolic activity of fibroblast growth factor 21"},{"issue":"13","key":"9809_CR18","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1101\/gad.1083503","volume":"17","author":"JA Holt","year":"2003","unstructured":"Holt JA, Luo G, Billin AN et al (2003 2003-07-01) Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev 17(13):1581\u20131591","journal-title":"Genes Dev"},{"issue":"23","key":"9809_CR19","doi-asserted-by":"publisher","first-page":"15694","DOI":"10.1074\/jbc.M601252200","volume":"281","author":"X Zhang","year":"2006","unstructured":"Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM (2006 2006-06-09) Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem 281(23):15694\u201315700","journal-title":"J Biol Chem"},{"issue":"1","key":"9809_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.febslet.2008.11.023","volume":"583","author":"J Yie","year":"2009","unstructured":"Yie J, Hecht R, Patel J et al (2009 2009-01-05) FGF21 N- and C-termini play different roles in receptor interaction and activation. FEBS Lett 583(1):19\u201324","journal-title":"FEBS Lett"},{"issue":"18","key":"9809_CR21","doi-asserted-by":"publisher","first-page":"7432","DOI":"10.1073\/pnas.0701600104","volume":"104","author":"Y Ogawa","year":"2007","unstructured":"Ogawa Y, Kurosu H, Yamamoto M et al (2007 2007-05-01) BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc Natl Acad Sci U S A 104(18):7432\u20137437","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9809_CR22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1747-0285.2012.01325.x","volume":"79","author":"J Yie","year":"2012","unstructured":"Yie J, Wang W, Deng L et al (2012 2012-04-01) Understanding the physical interactions in the FGF21\/FGFR\/beta-Klotho complex: structural requirements and implications in FGF21 signaling. Chem Biol Drug Des 79(4):398\u2013410","journal-title":"Chem Biol Drug Des"},{"key":"9809_CR23","doi-asserted-by":"crossref","unstructured":"Yang W, Chen X, Liu Y et al (2017 2017-09-01) N-3 polyunsaturated fatty acids increase hepatic fibroblast growth factor 21 sensitivity via a PPAR-gamma-beta-klotho pathway. Mol Nutr Food Res 61(9)","DOI":"10.1002\/mnfr.201601075"},{"issue":"2","key":"9809_CR24","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1096\/fj.15-274449","volume":"30","author":"K Kobayashi","year":"2016","unstructured":"Kobayashi K, Tanaka T, Okada S et al (2016 2016-02-01) Hepatocyte beta-Klotho regulates lipid homeostasis but not body weight in mice. FASEB J 30(2):849\u2013862","journal-title":"FASEB J"},{"issue":"6","key":"9809_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.molmet.2017.03.009","volume":"6","author":"KR Markan","year":"2017","unstructured":"Markan KR, Naber MC, Small SM, Peltekian L, Kessler RL, Potthoff MJ (2017 2017-06-01) FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue. Mol Metab 6(6):602\u2013610","journal-title":"Mol Metab"},{"issue":"21","key":"9809_CR26","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.115.015308","volume":"131","author":"Z Lin","year":"2015","unstructured":"Lin Z, Pan X, Wu F et al (2015 2015-05-26) Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice. Circulation 131(21):1861\u20131871","journal-title":"Circulation"},{"issue":"1","key":"9809_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/cen.12134","volume":"80","author":"Y Lee","year":"2014","unstructured":"Lee Y, Lim S, Hong ES et al (2014 2014-01-01) Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status. Clin Endocrinol (Oxf) 80(1):57\u201364","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9809_CR28","doi-asserted-by":"crossref","unstructured":"Cuevas-Ramos D, Aguilar-Salinas CA (2016 2016-06-20) Modulation of energy balance by fibroblast growth factor 21. Horm Mol Biol Clin Investig 30(1)","DOI":"10.1515\/hmbci-2016-0023"},{"issue":"10","key":"9809_CR29","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s00125-017-4373-5","volume":"60","author":"R Kruse","year":"2017","unstructured":"Kruse R, Vienberg SG, Vind BF, Andersen B, Hojlund K (2017 2017-10-01) Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes. Diabetologia 60(10):2042\u20132051","journal-title":"Diabetologia"},{"issue":"2","key":"9809_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000443800","volume":"68","author":"I Velasco","year":"2016","unstructured":"Velasco I, Santos C, Limon J et al (2016 2016-01-20) Bioactive components in human milk along the first month of life: effects of iodine supplementation during pregnancy. Ann Nutr Metab 68(2):130\u2013136","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"9809_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11845-017-1554-7","volume":"186","author":"A Esteghamati","year":"2017","unstructured":"Esteghamati A, Khandan A, Momeni A et al (2017 2017-08-01) Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease. Ir J Med Sci 186(3):785\u2013794","journal-title":"Ir J Med Sci"},{"key":"9809_CR32","first-page":"1540267","volume":"2016","author":"P Cheng","year":"2016","unstructured":"Cheng P, Zhang F, Yu L et al (2016 2016-01-20) Physiological and pharmacological roles of FGF21 in cardiovascular diseases. J Diabetes Res 2016:1540267","journal-title":"J Diabetes Res"},{"key":"9809_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pharmthera.2017.05.013","volume":"179","author":"M Presta","year":"2017","unstructured":"Presta M, Chiodelli P, Giacomini A, Rusnati M, Ronca R (2017 2017-11-01) Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach. Pharmacol Ther 179:171\u2013187","journal-title":"Pharmacol Ther"},{"key":"9809_CR34","first-page":"110","volume":"4","author":"N Itoh","year":"2016","unstructured":"Itoh N, Ohta H, Nakayama Y, Konishi M (2016 2016-01-20) Roles of FGF signals in heart development, health, and disease. Front Cell Dev Biol 4:110","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"9809_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1530\/EJE-14-0539","volume":"172","author":"M Olszanecka-Glinianowicz","year":"2015","unstructured":"Olszanecka-Glinianowicz M, Madej P, Wdowczyk M, Owczarek A, Chudek J (2015 2015-02-01) Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome. Eur J Endocrinol 172(2):173\u2013179","journal-title":"Eur J Endocrinol"},{"key":"9809_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cca.2012.09.019","volume":"414","author":"SL Su","year":"2012","unstructured":"Su SL, Wang WF, Wu SL et al (2012 2012-12-24) FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease. Clin Chim Acta 414:225\u2013227","journal-title":"Clin Chim Acta"},{"issue":"6","key":"9809_CR37","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.celrep.2018.07.023","volume":"24","author":"LM Restelli","year":"2018","unstructured":"Restelli LM, Oettinghaus B, Halliday M et al (2018 2018-08-07) Neuronal mitochondrial dysfunction activates the integrated stress response to induce fibroblast growth factor 21. Cell Rep 24(6):1407\u20131414","journal-title":"Cell Rep"},{"issue":"3","key":"9809_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/1535370219828692","volume":"244","author":"G Cai","year":"2019","unstructured":"Cai G, Liu J, Wang M et al (2019 2019-03-01) Mutual promotion of FGF21 and PPARgamma attenuates hypoxia-induced pulmonary hypertension. Exp Biol Med (Maywood) 244(3):252\u2013261","journal-title":"Exp Biol Med (Maywood)"},{"issue":"4","key":"9809_CR39","first-page":"458","volume":"67","author":"L Cieszynski","year":"2016","unstructured":"Cieszynski L, Berendt-Obolonczyk M, Szulc M, Sworczak K (2016 2016-01-20) Cushing's syndrome due to ectopic ACTH secretion. Endokrynol Pol 67(4):458\u2013471","journal-title":"Endokrynol Pol"},{"issue":"3","key":"9809_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1677\/JOE-07-0230","volume":"196","author":"Z Li","year":"2008","unstructured":"Li Z, Zhang T, Dai H et al (2008 2008-03-01) Endoplasmic reticulum stress is involved in myocardial apoptosis of streptozocin-induced diabetic rats. J Endocrinol 196(3):565\u2013572","journal-title":"J Endocrinol"},{"issue":"2","key":"9809_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41419-018-0307-5","volume":"9","author":"H Yang","year":"2018","unstructured":"Yang H, Feng A, Lin S et al (2018 2018-02-14) Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart. Cell Death Dis 9(2):227","journal-title":"Cell Death Dis"},{"issue":"11","key":"9809_CR42","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1139\/cjpp-2012-0441","volume":"91","author":"WT Cong","year":"2013","unstructured":"Cong WT, Ling J, Tian HS et al (2013 2013-11-01) Proteomic study on the protective mechanism of fibroblast growth factor 21 to ischemia-reperfusion injury. Can J Physiol Pharmacol 91(11):973\u2013984","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"9809_CR43","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3892\/ijmm.2017.3140","volume":"40","author":"P Liang","year":"2017","unstructured":"Liang P, Zhong L, Gong L et al (2017 2017-01-01) Fibroblast growth factor 21 protects rat cardiomyocytes from endoplasmic reticulum stress by promoting the fibroblast growth factor receptor 1-extracellular signal-regulated kinase 1\/2 signaling pathway. Int J Mol Med 40(5):1477\u20131485","journal-title":"Int J Mol Med"},{"issue":"27","key":"9809_CR44","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","volume":"582","author":"Y Izumiya","year":"2008","unstructured":"Izumiya Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A, Walsh K (2008 2008-11-12) FGF21 is an Akt-regulated myokine. FEBS Lett 582(27):3805\u20133810","journal-title":"FEBS Lett"},{"key":"9809_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.taap.2015.11.012","volume":"290","author":"P Xu","year":"2016","unstructured":"Xu P, Zhang Y, Liu Y et al (2016 2016-01-01) Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-beta\/smad2\/3 and NF-kappaB signaling pathways. Toxicol Appl Pharmacol 290:43\u201353","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"9809_CR46","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1016\/j.bbagen.2012.11.016","volume":"1830","author":"JH Wu","year":"2013","unstructured":"Wu JH, Batist G (2013 2013-05-01) Glutathione and glutathione analogues; therapeutic potentials. Biochim Biophys Acta 1830(5):3350\u20133353","journal-title":"Biochim Biophys Acta"},{"key":"9809_CR47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.redox.2016.12.024","volume":"11","author":"MA Gomez-Samano","year":"2017","unstructured":"Gomez-Samano MA, Grajales-Gomez M, Zuarth-Vazquez JM et al (2017 2017-04-01) Fibroblast growth factor 21 and its novel association with oxidative stress. Redox Biol 11:335\u2013341","journal-title":"Redox Biol"},{"issue":"1","key":"9809_CR48","first-page":"50","volume":"61","author":"B Matuszek","year":"2010","unstructured":"Matuszek B, Lenart-Lipinska M, Duma D, Solski J, Nowakowski A (2010 2010-01-01) Evaluation of concentrations of FGF-21\u2014a new adipocytokine in type 2 diabetes. Endokrynol Pol 61(1):50\u201354","journal-title":"Endokrynol Pol"},{"key":"9809_CR49","doi-asserted-by":"publisher","first-page":"43123","DOI":"10.1038\/srep43123","volume":"7","author":"X Li","year":"2017","unstructured":"Li X, Yu H, Yin J et al (2017 2017-02-22) Decreased levels of fibroblast growth factor 21 are correlated with improved hypoglycemia in patients with insulinoma. Sci Rep 7:43123","journal-title":"Sci Rep"},{"key":"9809_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-2-1","volume":"2","author":"C Bauters","year":"2003","unstructured":"Bauters C, Lamblin N, Mc FE, Van Belle E, Millaire A, de Groote P (2003 2003-01-08) Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol 2:1","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"9809_CR51","doi-asserted-by":"publisher","first-page":"632","DOI":"10.5966\/sctm.2015-0172","volume":"5","author":"B Vrtovec","year":"2016","unstructured":"Vrtovec B, Sever M, Jensterle M et al (2016 2016-05-01) Efficacy of CD34+ stem cell therapy in nonischemic dilated cardiomyopathy is absent in patients with diabetes but preserved in patients with insulin resistance. Stem Cells Transl Med 5(5):632\u2013638","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"9809_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3892\/br.2016.749","volume":"5","author":"JW Luo","year":"2016","unstructured":"Luo JW, Zheng X, Cheng GC, Ye QH, Deng YZ, Wu L (2016 2016-10-01) Resistin-induced cardiomyocyte hypertrophy is inhibited by apelin through the inactivation of extracellular signal-regulated kinase signaling pathway in H9c2 embryonic rat cardiomyocytes. Biomed Rep 5(4):473\u2013478","journal-title":"Biomed Rep"},{"issue":"7","key":"9809_CR53","first-page":"926","volume":"32","author":"T Xu","year":"2016","unstructured":"Xu T, Liu Y, Deng Y et al (2016 2016-07-01) [Insulin combined with selenium inhibit p38MAPK\/CBP pathway and suppresses cardiomyocyte apoptosis in rats with diabetic cardiomyopathy]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 32(7):926\u2013930","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"9809_CR54","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","volume":"133","author":"Y Yue","year":"2017","unstructured":"Yue Y, Meng K, Pu Y, Zhang X (2017 2017-09-01) Transforming growth factor beta (TGF-beta) mediates cardiac fibrosis and induces diabetic cardiomyopathy. Diabetes Res Clin Pract 133:124\u2013130","journal-title":"Diabetes Res Clin Pract"},{"key":"9809_CR55","doi-asserted-by":"crossref","unstructured":"Alonso N, Moliner P, Mauricio D (2017) Pathogenesis, clinical features and treatment of diabetic cardiomyopathy. Adv Exp Med Biol. 2017-10-05","DOI":"10.1007\/5584_2017_105"},{"key":"9809_CR56","unstructured":"Jia G, Whaley-Connell A, Sowers JR (2017) Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2017-08-03"},{"issue":"6","key":"9809_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972 1972-11-08) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30(6):595\u2013602","journal-title":"Am J Cardiol"},{"issue":"8","key":"9809_CR58","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.jacc.2006.07.033","volume":"48","author":"M Galderisi","year":"2006","unstructured":"Galderisi M (2006 2006-10-17) Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 48(8):1548\u20131551","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"9809_CR59","first-page":"275","volume":"21","author":"Y Gu","year":"2013","unstructured":"Gu Y, Warren J, Walker N, Kennelly J (2013 2013-01-20) Gender differences in cardiovascular disease risk management for Pacific Islanders in primary care. Qual Prim Care 21(5):275\u2013285","journal-title":"Qual Prim Care"},{"issue":"1","key":"9809_CR60","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.1152\/ajpendo.00026.2015","volume":"309","author":"M Shao","year":"2015","unstructured":"Shao M, Yu L, Zhang F et al (2015 2015-07-01) Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model. Am J Physiol Endocrinol Metab 309(1):E45\u2013E54","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"17","key":"9809_CR61","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1089\/ars.2015.6305","volume":"22","author":"MM Sung","year":"2015","unstructured":"Sung MM, Hamza SM, Dyck JR (2015 2015-06-10) Myocardial metabolism in diabetic cardiomyopathy: potential therapeutic targets. Antioxid Redox Signal 22(17):1606\u20131630","journal-title":"Antioxid Redox Signal"},{"key":"9809_CR62","doi-asserted-by":"crossref","unstructured":"Bell D, Goncalves E (2019) Heart failure in the patient with diabetes: epidemiology, aetiology, prognosis, therapy and the effect of glucose-lowering medications. Diabetes Obes Metab. 2019-02-05","DOI":"10.1111\/dom.13652"},{"key":"9809_CR63","doi-asserted-by":"crossref","unstructured":"Schutt K, Marx N (2019) Heart failure and diabetes: management and open issues. Herz. 2019-03-07","DOI":"10.1007\/s00059-019-4792-9"},{"issue":"7","key":"9809_CR64","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.2337\/db12-1391","volume":"62","author":"S Lei","year":"2013","unstructured":"Lei S, Li H, Xu J et al (2013 2013-07-01) Hyperglycemia-induced protein kinase C beta2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt\/eNOS signaling. Diabetes 62(7):2318\u20132328","journal-title":"Diabetes"},{"issue":"4","key":"9809_CR65","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s10495-008-0302-x","volume":"14","author":"Y Lee","year":"2009","unstructured":"Lee Y, Gustafsson AB (2009 2009-04-01) Role of apoptosis in cardiovascular disease. Apoptosis 14(4):536\u2013548","journal-title":"Apoptosis"},{"issue":"9","key":"9809_CR66","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1089\/ars.2009.2686","volume":"11","author":"RC Austin","year":"2009","unstructured":"Austin RC (2009 2009-09-01) The unfolded protein response in health and disease. Antioxid Redox Signal 11(9):2279\u20132287","journal-title":"Antioxid Redox Signal"},{"key":"9809_CR67","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2193-1801-3-2","volume":"3","author":"J Makela","year":"2014","unstructured":"Makela J, Tselykh TV, Maiorana F et al (2014 2014-01-20) Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1alpha in human dopaminergic neurons via Sirtuin-1. SpringerPlus 3:2","journal-title":"SpringerPlus"},{"issue":"12","key":"9809_CR68","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nrd2755","volume":"7","author":"I Kim","year":"2008","unstructured":"Kim I, Xu W, Reed JC (2008 2008-12-01) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 7(12):1013\u20131030","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"9809_CR69","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/CIRCRESAHA.110.227819","volume":"107","author":"T Minamino","year":"2010","unstructured":"Minamino T, Komuro I, Kitakaze M (2010 2010-10-29) Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ Res 107(9):1071\u20131082","journal-title":"Circ Res"},{"issue":"6","key":"9809_CR70","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.yjmcc.2009.10.026","volume":"48","author":"T Minamino","year":"2010","unstructured":"Minamino T, Kitakaze M (2010 2010-06-01) ER stress in cardiovascular disease. J Mol Cell Cardiol 48(6):1105\u20131110","journal-title":"J Mol Cell Cardiol"},{"key":"9809_CR71","first-page":"807874","volume":"2014","author":"XS Wan","year":"2014","unstructured":"Wan XS, Lu XH, Xiao YC et al (2014 2014-01-20) ATF4- and CHOP-dependent induction of FGF21 through endoplasmic reticulum stress. Biomed Res Int 2014:807874","journal-title":"Biomed Res Int"},{"issue":"2\u20133","key":"9809_CR72","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0014-5793(02)02289-5","volume":"514","author":"RV Rao","year":"2002","unstructured":"Rao RV, Peel A, Logvinova A et al (2002 2002-03-13) Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 514(2\u20133):122\u2013128","journal-title":"FEBS Lett"},{"issue":"5453","key":"9809_CR73","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.287.5453.664","volume":"287","author":"F Urano","year":"2000","unstructured":"Urano F, Wang X, Bertolotti A et al (2000 2000-01-28) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287(5453):664\u2013666","journal-title":"Science"},{"issue":"12","key":"9809_CR74","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1210\/en.2016-1710","volume":"157","author":"M Ye","year":"2016","unstructured":"Ye M, Lu W, Wang X et al (2016 2016-12-01) FGF21-FGFR1 coordinates phospholipid homeostasis, lipid droplet function, and ER stress in obesity. Endocrinology 157(12):4754\u20134769","journal-title":"Endocrinology"},{"issue":"3","key":"9809_CR75","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12013-007-0008-7","volume":"47","author":"WW Winder","year":"2007","unstructured":"Winder WW, Thomson DM (2007 2007-01-20) Cellular energy sensing and signaling by AMP-activated protein kinase. Cell Biochem Biophys 47(3):332\u2013347","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"9809_CR76","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1079\/PNS2004339","volume":"63","author":"EO Ojuka","year":"2004","unstructured":"Ojuka EO (2004 2004-05-01) Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc 63(2):275\u2013278","journal-title":"Proc Nutr Soc"},{"issue":"2","key":"9809_CR77","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/cvr\/cvr034","volume":"90","author":"C Beauloye","year":"2011","unstructured":"Beauloye C, Bertrand L, Horman S, Hue L (2011 2011-05-01) AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res 90(2):224\u2013233","journal-title":"Cardiovasc Res"},{"issue":"3","key":"9809_CR78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bcp.2011.04.004","volume":"82","author":"A Morrison","year":"2011","unstructured":"Morrison A, Li J (2011 2011-08-01) PPAR-gamma and AMPK\u2014advantageous targets for myocardial ischemia\/reperfusion therapy. Biochem Pharmacol 82(3):195\u2013200","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"9809_CR79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1160\/TH13-02-0155","volume":"110","author":"Y Asare","year":"2013","unstructured":"Asare Y, Shagdarsuren E, Schmid JA et al (2013 2013-07-01) Endothelial CSN5 impairs NF-kappaB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions. Thromb Haemost 110(1):141\u2013152","journal-title":"Thromb Haemost"},{"issue":"1\u20132","key":"9809_CR80","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","volume":"168","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Lenardo MJ, Baltimore D (2017 2017-01-12) 30\u00a0years of NF-kappaB: a blossoming of relevance to human pathobiology. Cell 168(1\u20132):37\u201357","journal-title":"Cell"},{"issue":"4","key":"9809_CR81","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/cvr\/cvx011","volume":"113","author":"G Frati","year":"2017","unstructured":"Frati G, Schirone L, Chimenti I et al (2017 2017-03-15) An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. Cardiovasc Res 113(4):378\u2013388","journal-title":"Cardiovasc Res"},{"issue":"22","key":"9809_CR82","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","volume":"13","author":"SR Datta","year":"1999","unstructured":"Datta SR, Brunet A, Greenberg ME (1999 1999-11-15) Cellular survival: a play in three Akts. Genes Dev 13(22):2905\u20132927","journal-title":"Genes Dev"},{"issue":"24","key":"9809_CR83","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1101\/gad.1492806","volume":"20","author":"I Shiojima","year":"2006","unstructured":"Shiojima I, Walsh K (2006 2006-12-15) Regulation of cardiac growth and coronary angiogenesis by the Akt\/PKB signaling pathway. Genes Dev 20(24):3347\u20133365","journal-title":"Genes Dev"},{"issue":"12","key":"9809_CR84","doi-asserted-by":"publisher","first-page":"e52013","DOI":"10.1371\/journal.pone.0052013","volume":"7","author":"W Yu","year":"2012","unstructured":"Yu W, Wu J, Cai F et al (2012 2012-01-20) Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. Plos One 7(12):e52013","journal-title":"Plos One"},{"issue":"6","key":"9809_CR85","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.3892\/mmr.2017.6456","volume":"15","author":"Y Yu","year":"2017","unstructured":"Yu Y, Zheng G (2017 2017-06-01) Troxerutin protects against diabetic cardiomyopathy through NFkappaB\/AKT\/IRS1 in a rat model of type 2 diabetes. Mol Med Rep 15(6):3473\u20133478","journal-title":"Mol Med Rep"},{"issue":"5","key":"9809_CR86","doi-asserted-by":"publisher","first-page":"757","DOI":"10.33549\/physiolres.932134","volume":"60","author":"T Kotulak","year":"2011","unstructured":"Kotulak T, Drapalova J, Kopecky P et al (2011 2011-01-20) Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance. Physiol Res 60(5):757\u2013767","journal-title":"Physiol Res"},{"key":"9809_CR87","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/ncomms3019","volume":"4","author":"A Planavila","year":"2013","unstructured":"Planavila A, Redondo I, Hondares E et al (2013 2013-01-20) Fibroblast growth factor 21 protects against cardiac hypertrophy in mice. Nat Commun 4:2019","journal-title":"Nat Commun"},{"issue":"3","key":"9809_CR88","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCRESAHA.114.300559","volume":"114","author":"YR Chen","year":"2014","unstructured":"Chen YR, Zweier JL (2014 2014-01-31) Cardiac mitochondria and reactive oxygen species generation. Circ Res 114(3):524\u2013537","journal-title":"Circ Res"},{"issue":"4","key":"9809_CR89","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4093\/dmj.2012.36.4.255","volume":"36","author":"S Sasaki","year":"2012","unstructured":"Sasaki S, Inoguchi T (2012 2012-08-01) The role of oxidative stress in the pathogenesis of diabetic vascular complications. Diabetes Metab J 36(4):255\u2013261","journal-title":"Diabetes Metab J"},{"issue":"1","key":"9809_CR90","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-017-0379-z","volume":"24","author":"W Ahmad","year":"2017","unstructured":"Ahmad W, Ijaz B, Shabbiri K, Ahmed F, Rehman S (2017 2017-09-19) Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS\/ RNS generation. J Biomed Sci 24(1):76","journal-title":"J Biomed Sci"},{"issue":"6","key":"9809_CR91","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/01.CIR.0000083716.82622.FD","volume":"108","author":"LA Barouch","year":"2003","unstructured":"Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM (2003 2003-08-12) Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108(6):754\u2013759","journal-title":"Circulation"},{"key":"9809_CR92","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1038\/sj.ki.5002382","volume":"106","author":"E Schleicher","year":"2007","unstructured":"Schleicher E, Friess U (2007 2007-08-01) Oxidative stress, AGE, and atherosclerosis. Kidney Int Suppl 106:S17\u2013S26","journal-title":"Kidney Int Suppl"},{"key":"9809_CR93","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.freeradbiomed.2015.02.009","volume":"83","author":"K Zhu","year":"2015","unstructured":"Zhu K, Kakehi T, Matsumoto M et al (2015 2015-06-01) NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney. Free Radic Biol Med 83:21\u201330","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"9809_CR94","doi-asserted-by":"publisher","first-page":"e6500","DOI":"10.1371\/journal.pone.0006500","volume":"4","author":"G Lacraz","year":"2009","unstructured":"Lacraz G, Figeac F, Movassat J et al (2009 2009-08-05) Diabetic beta-cells can achieve self-protection against oxidative stress through an adaptive up-regulation of their antioxidant defenses. Plos One 4(8):e6500","journal-title":"Plos One"},{"issue":"10","key":"9809_CR95","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1248\/bpb.b13-00292","volume":"36","author":"G Koh","year":"2013","unstructured":"Koh G, Yang EJ, Kim MK, Lee SA, Lee DH (2013 2013-01-20) Alpha-lipoic acid treatment reverses 2-deoxy-D-ribose-induced oxidative damage and suppression of insulin expression in pancreatic beta-cells. Biol Pharm Bull 36(10):1570\u20131576","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"9809_CR96","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.bbrc.2017.10.027","volume":"493","author":"P Liu","year":"2017","unstructured":"Liu P, Su J, Song X, Wang S (2017 2017-12-02) Activation of nuclear beta-catenin\/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy. Biochem Biophys Res Commun 493(4):1573\u20131580","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"9809_CR97","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/1076029608323087","volume":"15","author":"B Guldiken","year":"2009","unstructured":"Guldiken B, Demir M, Guldiken S, Turgut N, Turgut B, Tugrul A (2009 2009-12-01) Oxidative stress and total antioxidant capacity in diabetic and nondiabetic acute ischemic stroke patients. Clin Appl Thromb Hemost 15(6):695\u2013700","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"9809_CR98","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1124\/mol.62.5.1001","volume":"62","author":"KW Kang","year":"2002","unstructured":"Kang KW, Lee SJ, Park JW, Kim SG (2002 2002-11-01) Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol Pharmacol 62(5):1001\u20131010","journal-title":"Mol Pharmacol"},{"issue":"5","key":"9809_CR99","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1042\/CBI20100900","volume":"36","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Huang WD, Lv XY, Yang YM (2012 2012-05-01) Puerarin protects differentiated PC12 cells from H(2)O(2)-induced apoptosis through the PI3K\/Akt signalling pathway. Cell Biol Int 36(5):419\u2013426","journal-title":"Cell Biol Int"},{"issue":"1\u20133","key":"9809_CR100","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejphar.2007.04.031","volume":"568","author":"J Fu","year":"2007","unstructured":"Fu J, Huang H, Liu J, Pi R, Chen J, Liu P (2007 2007-07-30) Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 568(1\u20133):213\u2013221","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"9809_CR101","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1023\/B:JOCI.0000010421.56035.60","volume":"23","author":"AB Gustafsson","year":"2003","unstructured":"Gustafsson AB, Gottlieb RA (2003 2003-11-01) Mechanisms of apoptosis in the heart. J Clin Immunol 23(6):447\u2013459","journal-title":"J Clin Immunol"},{"issue":"7","key":"9809_CR102","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.fct.2010.04.047","volume":"48","author":"H Tabassum","year":"2010","unstructured":"Tabassum H, Parvez S, Pasha ST, Banerjee BD, Raisuddin S (2010 2010-07-01) Protective effect of lipoic acid against methotrexate-induced oxidative stress in liver mitochondria. Food Chem Toxicol 48(7):1973\u20131979","journal-title":"Food Chem Toxicol"},{"issue":"5381","key":"9809_CR103","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","volume":"281","author":"JM Adams","year":"1998","unstructured":"Adams JM, Cory S (1998 1998-08-28) The Bcl-2 protein family: arbiters of cell survival. Science 281(5381):1322\u20131326","journal-title":"Science"},{"issue":"1","key":"9809_CR104","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12872-017-0549-7","volume":"17","author":"Y Sun","year":"2017","unstructured":"Sun Y, Su Q, Li L, Wang X, Lu Y, Liang J (2017 2017-05-10) MiR-486 regulates cardiomyocyte apoptosis by p53-mediated BCL-2 associated mitochondrial apoptotic pathway. BMC Cardiovasc Disord 17(1):119","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"9809_CR105","first-page":"470","volume":"49","author":"MM Han","year":"2014","unstructured":"Han MM, Wang WF, Liu MY et al (2014 2014-04-01) FGF-21 protects H9c2 cardiomyoblasts against hydrogen peroxide-induced oxidative stress injury. Yao Xue Xue Bao 49(4):470\u2013475","journal-title":"Yao Xue Xue Bao"},{"issue":"1","key":"9809_CR106","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.intimp.2015.01.005","volume":"25","author":"Y Yu","year":"2015","unstructured":"Yu Y, Li S, Liu Y et al (2015 2015-03-01) Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway. Int Immunopharmacol 25(1):74\u201382","journal-title":"Int Immunopharmacol"},{"issue":"40","key":"9809_CR107","doi-asserted-by":"publisher","first-page":"34533","DOI":"10.1074\/jbc.M111.248591","volume":"286","author":"X Ge","year":"2011","unstructured":"Ge X, Chen C, Hui X, Wang Y, Lam KS, Xu A (2011 2011-10-07) Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor\/Ets-like protein-1 in adipocytes. J Biol Chem 286(40):34533\u201334541","journal-title":"J Biol Chem"},{"issue":"7","key":"9809_CR108","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/jcmm.12530","volume":"19","author":"X Yan","year":"2015","unstructured":"Yan X, Chen J, Zhang C et al (2015 2015-07-01) FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation. J Cell Mol Med 19(7):1557\u20131568","journal-title":"J Cell Mol Med"},{"issue":"26","key":"9809_CR109","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.1073\/pnas.0904187106","volume":"106","author":"MJ Potthoff","year":"2009","unstructured":"Potthoff MJ, Inagaki T, Satapati S et al (2009 2009-06-30) FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A 106(26):10853\u201310858","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9\u201310","key":"9809_CR110","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1242\/dmm.001941","volume":"2","author":"H Bugger","year":"2009","unstructured":"Bugger H, Abel ED (2009 2009-09-01) Rodent models of diabetic cardiomyopathy. Dis Model Mech 2(9\u201310):454\u2013466","journal-title":"Dis Model Mech"},{"issue":"1","key":"9809_CR111","doi-asserted-by":"publisher","first-page":"E54","DOI":"10.1210\/jc.2011-1930","volume":"97","author":"Y Xiao","year":"2012","unstructured":"Xiao Y, Xu A, Law LS et al (2012 2012-01-01) Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes. J Clin Endocrinol Metab 97(1):E54\u2013E58","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"9809_CR112","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.RES.0000264104.25265.b6","volume":"100","author":"J Yang","year":"2007","unstructured":"Yang J, Sambandam N, Han X et al (2007 2007-04-27) CD36 deficiency rescues lipotoxic cardiomyopathy. Circ Res 100(8):1208\u20131217","journal-title":"Circ Res"},{"issue":"5","key":"9809_CR113","doi-asserted-by":"publisher","first-page":"e37633","DOI":"10.1371\/journal.pone.0037633","volume":"7","author":"A Geloen","year":"2012","unstructured":"Geloen A, Helin L, Geeraert B, Malaud E, Holvoet P, Marguerie G (2012 2012-01-20) CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis. Plos One 7(5):e37633","journal-title":"Plos One"},{"issue":"1","key":"9809_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00424-003-1199-4","volume":"448","author":"JJ Luiken","year":"2004","unstructured":"Luiken JJ, Coort SL, Koonen DP et al (2004 2004-04-01) Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters. Pflugers Arch 448(1):1\u201315","journal-title":"Pflugers Arch"},{"issue":"3","key":"9809_CR115","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1172\/JCI118173","volume":"96","author":"DE Greenwalt","year":"1995","unstructured":"Greenwalt DE, Scheck SH, Rhinehart-Jones T (1995 1995-09-01) Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J Clin Invest 96(3):1382\u20131388","journal-title":"J Clin Invest"},{"issue":"3","key":"9809_CR116","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3892\/br.2015.436","volume":"3","author":"T Fukuda","year":"2015","unstructured":"Fukuda T, Fukui M, Tanaka M et al (2015 2015-05-01) Effect of Brazilian green propolis in patients with type 2 diabetes: a double-blind randomized placebo-controlled study. Biomed Rep 3(3):355\u2013360","journal-title":"Biomed Rep"},{"issue":"6","key":"9809_CR117","doi-asserted-by":"publisher","first-page":"C499","DOI":"10.1152\/ajpcell.00006.2014","volume":"307","author":"T Pham","year":"2014","unstructured":"Pham T, Loiselle D, Power A, Hickey AJ (2014 2014-09-15) Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart. Am J Physiol Cell Physiol 307(6):C499\u2013C507","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"9809_CR118","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCHEARTFAILURE.113.000672","volume":"7","author":"J Mori","year":"2014","unstructured":"Mori J, Patel VB, Abo AO et al (2014 2014-03-01) Angiotensin 1\u20137 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db\/db mice by reducing lipotoxicity and inflammation. Circ Heart Fail 7(2):327\u2013339","journal-title":"Circ Heart Fail"},{"issue":"27","key":"9809_CR119","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.2174\/1381612811319270003","volume":"19","author":"O Ilkun","year":"2013","unstructured":"Ilkun O, Boudina S (2013 2013-01-20) Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies. Curr Pharm Des 19(27):4806\u20134817","journal-title":"Curr Pharm Des"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09809-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09809-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09809-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:15:55Z","timestamp":1591398955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09809-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["9809"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09809-x","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"7 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not describe any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}